BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sumiyoshi T, Moriguchi M, Kanemoto H, Asakura K, Sasaki K, Sugiura T, Mizuno T, Uesaka K. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. Surg Today. 2012;42:200-204. [PMID: 22160355 DOI: 10.1007/s00595-011-0067-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zukotynski K, Kim CK. Abdomen. PET Clinics 2014;9:169-83. [DOI: 10.1016/j.cpet.2013.10.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) 2016;18:41-8. [PMID: 26776850 DOI: 10.1016/j.hpb.2015.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Arslan E, Çermik TF. PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas. Semin Nucl Med 2021;51:502-18. [PMID: 34049687 DOI: 10.1053/j.semnuclmed.2021.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Young JR, Graham RP, Venkatesh SK, Kendi AT. 18F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature. Abdom Radiol (NY) 2021;46:2604-9. [PMID: 33555390 DOI: 10.1007/s00261-021-02968-2] [Reference Citation Analysis]
5 Sureka B, Rastogi A, Mukund A, Sarin SK. False-positive 18F fluorodeoxyglucose positron emission tomography-avid benign hepatic tumor: Previously unreported in a male patient. Indian J Radiol Imaging 2018;28:200-4. [PMID: 30050244 DOI: 10.4103/ijri.IJRI_170_17] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lee SY, Kingham TP, LaGratta MD, Jessurun J, Cherqui D, Jarnagin WR, Kluger MD. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions. HPB (Oxford) 2015. [PMID: 26472264 DOI: 10.1111/hpb.12489] [Reference Citation Analysis]
7 Ozaki K, Harada K, Terayama N, Matsui O, Saitoh S, Tomimaru Y, Fujii T, Gabata T. Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation. Br J Radiol 2016;89:20160265. [PMID: 27197745 DOI: 10.1259/bjr.20160265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Lim D, Lee SY, Lim KH, Chan CY. Hepatic adenoma mimicking a metastatic lesion on computed tomography-positron emission tomography scan. World J Gastroenterol 2013; 19(27): 4432-4436 [PMID: 23885159 DOI: 10.3748/wjg.v19.i27.4432] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
9 Liu W, Delwaide J, Bletard N, Delvenne P, Meunier P, Hustinx R, Detry O. 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World J Hepatol 2017; 9(11): 562-566 [PMID: 28469812 DOI: 10.4254/wjh.v9.i11.562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Nakashima T, Takayama Y, Nishie A, Asayama Y, Baba S, Yamashita Y, Shirabe K, Kubo Y, Hida T, Honda H. Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2). Clin Imaging. 2014;38:888-891. [PMID: 25034402 DOI: 10.1016/j.clinimag.2014.06.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]